Clinical Trials Browser

Phase 1/2 × siltuximab × Genitourinary × Clear all

NCT00265135 2014-07-03

A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma

Phase 1/2 Completed

Carcinoma, Renal Cell